Joost Louwagie
Innogenetics
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Joost Louwagie.
AIDS | 1994
Aleksei Bobkov; Rachanee Cheingsong-Popov; Mansur M. Garaev; Alla Rzhaninova; Pontiano Kaleebu; Simon Beddows; Michael H. Bachmann; James I. Mullins; Joost Louwagie; Wouter Janssens; Guido van der Groen; Francine McCutchan; Jonathan Weber
ObjectiveTo identify HIV-1 envelope sequence subtypes in infected individuals from the Russian Federation and Belarus. PatientsA cohort of children infected after exposure to non-sterile needles during the 1988–1989 HIV-1 epidemic in southern Russia (n = 20) and HIV-1-seropositive individuals from Russia (n = 1) and Belarus (n = 7) infected via sexual transmission. MethodsDNA samples derived from peripheral blood mononuclear cells were analysed for their HIV-1 genotypes by the heteroduplex mobility assay (HMA). The 1.3 kilobase-pair env gene fragments encoding a portion of gp120 were amplified by nested polymerase chain reaction, cloned and sequenced. The env sequences derived from these patients were aligned and phylogenetic neighbour-joining and maximum parsimony-derived trees generated. ResultsThe env sequences derived from eight individuals infected in Russia and Belarus belong to subtype A (one), B (four), C (two), and D (one). Sequences derived from children, infected during parenteral manipulations in southern Russia, and one mother were closely related, but highly divergent, as a group, from all prototypic strains (genetic divergence, 17.2–22.9%). However, they clustered together with env sequences of the V1525 and LBV21–7 isolates from Gabon, recently described to be members of a new HIV-1 env subtype G. ConclusionExtensive heterogeneity of HIV-1 subtypes was evident in the Russian Federation and Belarus. Our data also support the existence of an HIV-1 env genetic subtype G, and such isolates are now apparently present on both the African and European continents. These variants were identified through V3 peptide enzyme-linked immunosorbent assay screening and subsequent HMA analysis. The combination of these techniques represents a model for screening HIV variants within a large population.
Journal of Virology | 1995
Joost Louwagie; Wouter Janssens; J Mascola; Leo Heyndrickx; P Hegerich; G. van der Groen; Francine McCutchan; Donald S. Burke
Archive | 1997
Lieven Stuyver; Joost Louwagie; Rudi Rossau
Clinical and Vaccine Immunology | 1998
Maan Zrein; Joost Louwagie; Hilde Boeykens; Loeki Govers; Greet Hendrickx; Fons Bosman; Erwin Sablon; Catherine Demarquilly; Michel Boniface; Eric Saman
Archive | 1999
Geert Maertens; Joost Louwagie; Alfons Bosman; Erwin Sablon; Maan Zrein
Archive | 2006
Geert Maertens; Joost Louwagie; Alfons Bosman; Erwin Sablon; Maan Zrein
Journal of Medical Virology | 2004
Marta Álvarez; Fernando Javier Nieto García; N.M. Martínez; J. Hernández Quero; Joost Louwagie; A. De Brauwer; Maroto Mc
Journal of Clinical Virology | 2004
Rainer Ziermann; Linda Celis; Inge Derdelinckx; Christine Lambert; Jürgen Veeck; Maria Gabriella Rizzo; Bart Vanderborght; Georges Zissis; Nathan Clumeck; Katrien Fransen; Dolores Vaira; David Hendricks; Kristel Van Laethem; Anne-Mieke Vandamme; Jean-Claude Schmit; Heribert Knechten; Andrea De Luca; Joost Louwagie; Pascale Segers; Kristel De Boeck; Hans Pottel; Annelies De Brauwer; Frank Hulstaert
Archive | 2005
Maertens Geert; Joost Louwagie; Alfons Bosman; Erwin Sablon; Maan Zrein
Antiviral Therapy | 2002
Linda Celis; K De Smet; Joost Louwagie; Inge Derdelinckx; A. De Luca; Heribert Knechten; Jc Schmit; B Vanderborght; A De Brauwer; Hans Pottel; D Hendriks; Rainer Ziermann; Frank Hulstaert